Details of the Drug

General Information of Drug (ID: DM811L4)

Drug Name

MNK-010

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02040558) Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors. U.S. National Institutes of Health.